Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers 拉丁名
(ATCC® 25285D-5™) 統(tǒng)一編號(hào)
Permits and Restrictions
View Permits
Verified By Whole-genome Sequencing
Strain Designations 別名 Genomic DNA from Bacteroides fragilis Strain VPI 2553 [ATCC® 25285™]
Biosafety Level 生物安全等級(jí) 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 dried
At least 5 µg in 1X TE buffer
OD260/OD280: 1.6 to 2.1
Preceptrol® no
Genome Sequenced Strain
Bacteroides fragilis NCTC 9343, complete genome
Type Strain yes
Comments 注釋 Genomic DNA from genome sequenced strain
This preparation of high molecular weight DNA is appropriate for use in the polymerase chain reaction (PCR)* process and other molecular biology applications.
*the PCR process is covered by patents owned by Hoffmann-La Roche Inc. Use of the PCR process requires a license.
Name of Depositor 寄存者 ATCC
Cross References 參考項(xiàng)
Nucleotide (GenBank) : X83935 B.fragilis 16S rRNA (ATCC 25285T).
Nucleotide (GenBank) : AX110196 Sequence 929 from Patent WO0123604.
Nucleotide (GenBank) : AF280705 Bacteroides fragilis isolate ATCC 25285 RecA (recA) gene, partial cds.
Nucleotide (GenBank) : U05887 Bacteroides fragilis ATCC 25285 beta-lactamase (cepA-85) gene, complete cds.
Nucleotide (GenBank) : AF280642 Bacteroides fragilis isolate ATCC 25285 glutamine synthetase (glnA) gene, partial cds.
Nucleotide (GenBank) : CR626927 Bacteroides fragilis NCTC 9343, complete genome
ATCC25285D-5
